LA

Limbabhai Arjanbhai Chovatia

Director Director DIN 01045898
DIN 01045898 First appointment Jan 2003 Primary industry Chemicals and Materials
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Jan 2003
Shareholding value β€’β€’β€’β€’ Premium profile

About Limbabhai Arjanbhai Chovatia

Data last updated:

Limbabhai Arjanbhai Chovatia was a Director at Ami Drugs And Speciality Chemicals Private Limited (2003–2015). The company operates in Chemicals and Materials.

DIN 01045898
Primary Designation Director
Industry Chemicals and Materials
First Appointment 28 Jan 2003

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Jan 20032003₹99.4 Lakh (FY 2021)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Ami Drugs And Speciality Chemicals Private Limited
Premium access

Shareholding and investment profile for Limbabhai Arjanbhai Chovatia

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Limbabhai Arjanbhai Chovatia

Limbabhai Arjanbhai Chovatia was first appointed on 28 Jan 2003 as Director at Ami Drugs And Speciality Chemicals Private Limited.

Limbabhai Arjanbhai Chovatia held 1 earlier board appointment: Ami Drugs And Speciality Chemicals Private Limited (Director, 28 Jan 2003 to 01 Aug 2015).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available